BiotechTube
Home/Avidicure/Dirk De Naeyer
DD

Dirk De Naeyer

COO

Avidicure

Therapeutic Areas

OncologyAutoimmune Diseases

Avidicure Pipeline

DrugIndicationPhase
AVC-S-201AML and other blood cancers/solid tumorsPreclinical

Leadership Team at Avidicure

AL
Arthur Lahr
CEO
RF
Robert Friesen
CSO
GS
Govert Schouten
CBO
View full Avidicure profile